Gunnar B.J. Andersson, M.D., Ph.D and world-renowned spine surgeon has become a director of TheraCell, Inc. and a member of the firm’s surgeon advisory committee. The appointment takes place immediately. Andersson’s appointment expands the board to five directors, two of whom are spine surgeons.
“Dr. Andersson’s 45 years of broad experience across both clinical and commercial aspects of the industry will add a valuable perspective to our Board of Directors, ” said Bradley E. Patt, Ph.D., Chairman and CEO. “We appreciate his willingness to serve as a director and look forward to benefiting from his judgment and input.”
Dr. Andersson is The Ronald L. DeWald, M.D. Professor and Chairman Emeritus of the Department of Orthopedic Surgery at Rush University Medical Center and a spine, back & neck surgeon at Midwest Orthopedics at Rush in Chicago. He was Chairman of the Department of Orthopedic Surgery from 1994 to 2008. Dr. Andersson has been at the forefront of spine surgery research and education for more than 30 years. He is a member of 17 editorial boards, editor-in-chief of Spinal News International, a deputy editor for Spine, founding editor of Contemporary Spine Surgery and an associate editor of Clinical Biomechanics. He is the author of approximately 330 original publications, over 160 books and book chapters and more than 530 abstracts.
Speaking of TheraCell, Inc., Andersson said, “TheraCell has become an exciting and promising company and I am delighted to participate. They have developed an exciting new platform of demineralized bone fiber products and are partnering with a well-established tissue bank to take these initial products to market. These initiatives will help accelerate revenues and give the company credibility. I like the idea of oxygenating the demineralized bone fiber matrix to help cells survive in a deep graft. I believe that the extended team is excellent and I look forward to working with them to help the company succeed.”
TheraCell, Inc. is a regenerative medicine company developing the next generation of advanced technologies for tissue repair for both the human and veterinary markets. The firm is headquartered in Los Angeles, California and maintains offices, laboratories and production facilities in Lowell, Massachusetts.
